EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals

Samer Adwan iD, Madeiha Qasmieh, Faisal Al-Akayleh, Ahmed Saad Abdulbari Ali Agha iD

Pharmaceuticals · 02.10.2024 · 17 (10) · 1315

DOI: 10.3390/ph17101315 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 02.10.2024. Verfasst von Samer Adwan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Zarqa University, Zarqa 13110, Jordan. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zarqa University, Deanship of Scientific Research at Zarqa University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: This review examines the evolution of lyotropic liquid crystals (LLCs) in ocular drug delivery, focusing on their ability to address the challenges associated with traditional ophthalmic formulations. This study aims to underscore the enhanced bioavailability, prolonged retention, and controlled release properties of LLCs that significantly improve therapeutic outcomes.

Methods

This review synthesizes data from various studies on both bulk-forming LLCs and liquid crystal nanoparticles (LCNPs). It also considers advanced analytical techniques, including the use of machine learning and AI-driven predictive modeling, to forecast the phase behavior and molecular structuring of LLC systems. Emerging technologies in biosensing and real-time diagnostics are discussed to illustrate the broader applicability of LLCs in ocular health.

Results

LLCs are identified as pivotal in promoting targeted drug delivery across different regions of the eye, with specific emphasis on the tailored optimization of LCNPs. This review highlights principal categories of LLCs used in ocular applications, each facilitating unique interactions with physiological systems to enhance drug efficacy and safety. Additionally, novel applications in biosensing demonstrate LLCs’ capacity to improve diagnostic processes.

Conclusions

Lyotropic liquid crystals offer transformative potential in ocular drug delivery by overcoming significant limitations of conventional delivery methods. The integration of predictive technologies and biosensing applications further enriches the utility of LLCs, indicating a promising future for their use in clinical settings. This review points to continued advancements and encourages further research in LLC technology to maximize its therapeutic benefits.

Schlagwörter

Stichwörter der Autor:innen

biosensing applicationsbulk formingcubosomesliquid crystal nanoparticleslyotropic liquid crystalsmachine learningocular drug delivery

Autor:innen und Institutionen

  • Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Zarqa University, Zarqa 13110, Jordan.
  • Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy and Medical Sciences, Petra University, Amman 11196, Jordan.
  • School of Pharmacy, Department of Pharmaceutical Sciences, The University of Jordan, Amman 11196, Jordan.

ORCID-Profile: Samer Adwan, Ahmed Saad Abdulbari Ali Agha

Förderung

  • Zarqa University
  • Deanship of Scientific Research at Zarqa University

Zitieren

APA

Adwan, S., Qasmieh, M., Al-Akayleh, F., & Ali Agha, A. S. A. (2024). Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals. Pharmaceuticals, 17(10), 1315. https://doi.org/10.3390/ph17101315

Vancouver

Adwan S, Qasmieh M, Al-Akayleh F, Ali Agha ASA. Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals. Pharmaceuticals. 2024;17(10):1315. doi:10.3390/ph17101315

BibTeX
@article{Adwan2024,
  author = {Adwan, Samer and Qasmieh, Madeiha and Al-Akayleh, Faisal and Ali Agha, Ahmed Saad Abdulbari},
  title = {Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {10},
  pages = {1315},
  doi = {10.3390/ph17101315}
}
Kostenlos starten →